LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway. Li Y, Zhao B, Gao W, Wu Y, et al. Clin Exp Med 2025;26:9.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Zhao B, Gao W, Wu Y, et al. LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway. Clin Exp Med 2025;26:9.
PMID: 41249576